Hester Biosciences

The company's business is structured across four primary verticals: Poultry Vaccines, Large Animal Vaccines, Poultry Health Products, and Animal Health Products. This diversified portfolio allows Hester to serve a broad client base, from smallholder farmers to large-scale poultry and livestock operations. Its revenue model is based on the manufacturing and sale of a wide range of products, including over 50 vaccines and more than 70 health products. Beyond products, Hester provides ancillary services like seroprofiling for poultry flocks and mastitis control programs for cattle, creating end-to-end solutions for its customers. The company has a significant market presence, holding approximately a 30-35% share of the Indian poultry vaccine market and a dominant 70% share in the domestic Goat Pox vaccine market.

Headquartered in Ahmedabad, India, Hester has expanded its operational footprint globally, with a strategic presence in over 30 countries and key markets in India, Nepal, and Tanzania. This international expansion includes manufacturing plants in Nepal, established as a joint venture with the Golchha Organisation, and a wholly-owned subsidiary in Tanzania, Hester Biosciences Africa Limited. The facility in Tanzania, partially funded by the Bill and Melinda Gates Foundation, aims to bridge the supply gap for animal vaccines across the African continent by developing vaccines specific to local diseases. The company has also established partnerships with organizations like GALVmed and has recently entered the Egyptian market through a collaboration with Novapharma.